Sharply Split Full Fed. Circ. Won't Eye Skinny Label Ruling
Six Federal Circuit judges on Friday said they won't disturb a panel's finding that generic-drug maker Teva induced doctors to infringe a GlaxoSmithKline patent with its "skinny-label" version of the drug...To view the full article, register now.
Already a subscriber? Click here to view full article